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The aim of this study was to characterize volatile and non-volatile compounds of rosemary from the
North Adriatic region and to determine its antiproliferative activity, alone or in combination with ra-
diomimetic bleomycin (BLM) on three malignant and one non-transformed human cell lines. Chemi-
cal analysis of the volatile compounds revealed the presence of monoterpenes (93.8%), among which
1.8-cineol (32.9%) and camphor (15.5%) were the dominant compounds. Also, obtained results showed
that the major polyphenolic constituents in rosemary extract were phenolic acids (rosmarinic acid and
its derivatives up to 69.2 mg 100 g-1), as well as flavones and flavonols in the following order: lute-
olin>isorhamnetin>quercetin>kaempferol>apigenin. Cell growth tests showed that rosemary extract
alone exerted moderate antiproliferative activity, as well as a synergistic antiproliferative effect with
bleomycin (EC50 344.3-461.5 µg mL-1 and 58.6-292 µg mL-1, respectively). The anti-tumor effect of
rosemary extract in combination with BLM was much stronger, compared to BLM itself on the breast
cancer cells. Through its proposed sensitizing effect, rosemary extract, in combination with the stan-
dard chemotherapeutics, could be used for the investigations of possible therapeutic modalities.
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1. INTRODUCTION
Among numerous spices and medicinal plants which are con-
sidered a promising source of natural products and various
bioactivities, Rosmarinus officinalis L. has been frequently re-
ported for its antiproliferative activity. In rosemary extracts
numerous components have been found and their content
depends on geographical origin (e.g. humidity, salinity, inso-
lation), cultivar and extraction methods. These ingredients
have a variety of extremely useful medicinal properties such
as anti-inflammatory, anti-allergic, anti-irritant, antibacterial,
antifungal, antioxidant and the most important for this inves-
tigation, anticancer (Leal et al., 2003; Kabouche et al., 2005;
Peng et al., 2005).
Primary bioactive principles of rosemary are: rosmarinic acid,
flavonoids and phenolic diterpens (carnosic acid and carnosol)
(Petiwala and Johnson, 2015). Essential oil also has remarkable
chemopreventive and anticancerogenic properties through
mechanisms such as antioxidant, antimutagenic, antiprolif-
erative and immunostimulatory mechanism of volatile con-
stituents (Ali et al., 2015).
Biological activity of rosemary and its constituents was in-
vestigated in numerous in vitro and in vivo studies using tu-
mor models. Antiproliferative and colony forming abilities
of rosemary were observed on many various cell lines includ-
ing leukemia (Cheung and Tai, 2007; Okumura et al., 2012),
prostate (Petiwala et al., 2014) and ovarian cancer (Tai et al.,
2012). Also, a number of studies regarding apoptosis and
cell death showed that treatment with rosemary extracts had
significantly reduced viability in various cell lines (Tai et al.,
2012; González-Vallinas et al., 2013; 2014). Furthermore, an-
tioxidative properties of rosemary in in vitro tumor cell models
(Slamenˇová et al., 2002; Alexandrov et al., 2006; Cheung and
Tai, 2007), as well as in vivo studies in experimental animals
with induced cancer were confirmed (Sancheti and Goyal,
2006).
Flavones present in rosemary are potent antiproliferative com-
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pounds whose activity is based on balance between their an-
tioxidative properties on one side, and their effect as prooxi-
dants and mitochondrial toxic agents on the other (Haddad
et al., 2006).
Also, caffeic and rosmarinic acid possess multiple biological
properties such as anti-inflammatory, antimicrobial, cardiopro-
tective and antitumor (Prasad et al., 2011; Bittner Fialová et al.,
2019). Recent in vivo studies showed that rosmarinic acid dose-
dependently suppresses growth of pancreatic cancer cells from
xenograft nude mice (Han et al., 2019). Also, it is known that
rosemary constituents potentiate the effectiveness of conven-
tional chemotherapeutics as well as other compounds of plant
origin through synergistic influence (Lewandowska et al.,
2014). Based on their investigations on a panel of colon cells,
Borrás-Linares et al. (2015) put forward a theory about the
synergistic action of rosemary extract ingredients. As it is de-
scribed by some authors (Ivanova et al., 2014a; Plouzek et al.,
1999), chemo-sensitising is the effect when biologically active
molecule increases the activity of chemotherapeutic in tumour
cells. Therefore, we included radiomimetic antitumor drug
bleomycin in treatment of cell lines with rosemary extract.
Namely, bleomycin, as free radical-based DNA damaging
agent, induces a double-strand breaks on deoxyribose moi-
eties in both DNA strands, interruption that is highly similar
to those of ionizing radiation (Povirk, 1996).
Having in mind the antitumor potential of rosemary con-
stituents and a lack of data concerning this medicinal plant
collected from the North Adriatic region, this study was con-
ducted to characterize volatile and non-volatile compounds of
rosemary harvested from the region of the Krk island (North
Adriatic). Secondarily, our aim was to evaluate antiprolifera-
tive activity of these compounds, alone or in combination with
bleomycin against human cell lines - one non-transformed hu-
man cell line MRC-5 and three malignant MCF-7 (breast ade-
nocarcinoma), HeLa (cervix epitheloid carcinoma) and HT-29
(colon adenocarcinoma) cell lines.
2. MATERIALS AND METHODS
2.1. Plant material
Aerial parts of the tested wild growing Rosmarinus offici-
nalis were collected at Mali Kijec-Omišalj, Krk Island (Croa-
tia), located in the Northern Adriatic (GPS coordinates
32°59′59.8′′N148°15′44.3′′E) in early June right before full blos-
soming. Voucher specimen was confirmed and deposited at
the Herbarium of the Department of Biology and Ecology, Fac-
ulty of Sciences, University of Novi Sad, Serbia (Voucher N
2-1527). Plants were air dried in shade, and after that pulver-
ized in a mortar with pestle and a coffee mill and used for
further analyses.
2.2. Determination of individual essential oil components
using GC-MS analysis
The essential oil was isolated by hydrodistillation method us-
ing n-hexane as collecting solvent, according to European Phar-
macopoeia (Ph.Eur.8.0, 2013). The obtained hexane extract was
dried over anhydrous sodium sulphate and decanted. Hexane
was evaporated under reduced pressure and the oil yield was
measured.
Gas chromatography-mass spectrometry (GC-MS) analysis
was carried out using Agilent 5975C Series GC-MSD system
(7890A GC and 5975C inert MSD), equipped with a HP-5MS
capillary column (30 m × 0.25 mm; film thickness 0.50 µm).
One µL of diluted essential oil (100 times in n-heptane) was
injected in split mode (10:1), and inlet temperature was held
at 250 °C. Helium was used as carrier gas in constant flow
mode at 1 mL min-1. The oven temperature was programmed
as follows: 70 °C increased to 104 °C (2 °C min-1) which was
held for 2 min, then to 180 °C (2 °C min-1 without holding),
and then to 200 °C (4 °C min-1) which was held for 10 min. Ion
source was operated at 70 EV, and mass spectra were acquired
in scan mode in the 50-550 m/z range. Essential oil components
were identified by comparing their retention indices and mass
spectra with those published by Adams (2007) and with Wiley
and NIST/NBS mass spectral libraries. A mixture of n-alkanes
from n-octane (C8) to eicosane (C20) was used for calculation
of Kovats retention indices (KI). ChemStation software (Agi-
lent Technologies) was used for data analysis, and curves used
for experimental estimation of KI were plotted and drawn
using SciDaVis software.
2.3. Preparation of rosemary extract
Extract of R. officinalis was prepared from 10 g of milled herba
extracted using maceration technique with 50 mL of 80% aque-
ous methanol, during 24 h at 4 °C. After filtration, the solvent
was evaporated at 40 °C and concentrated to dryness under
vacuum. Obtained dried extract was used for analyses of
polyphenolic compounds and cell growth activity tests.
2.4. Extraction and determination of phenolic compounds
using HPLC-DAD-MS analysis
Dried extract was dissolved in 80% methanol containing 1%
(w/v) 2.6-di-tert-butyl-4-methylphenol (BHT) to prevent oxi-
dation in a cooled ultrasonic bath for 1 h (final concentration
of the extract was 0.2 g mL-1). Obtained extract (in six replica-
tions) was centrifuged for 10 min at 1118 x g. Each supernatant
was filtered through the Chromafil AO-20/25 polyamide filter
produced by Macherey-Nagel (Düren, Germany) and trans-
ferred to a vial prior to injection into the HPLC (high perfor-
mance liquid chromatography) system. The solutions were
kept at -80 °C until further analysis. Phenolic compounds
were analyzed on a Thermo Finnigan Surveyor HPLC system
(Thermo Scientific, San Jose, USA) with a diode array detector
at 280 nm (cinnamic acid derivatives and flavanols) and 350
nm (flavonols and flavones). Spectra of the compounds were
recorded between 200 and 600 nm. The column was a Gem-
ini C18 (150 × 4.6 mm, 3 µm; Phenomenex, Torrance, USA)
operated at 25 °C. The elution solvents were aqueous 0.1%
formic acid in twice distilled water (A) and 0.1% formic acid
in acetonitrile (B). Samples were eluted according to the linear
gradient from 5% to 20% B in the first 15 min, followed by a
linear gradient from 20% to 30% B for 5 min, then an isocratic
mixture for 5 min, followed by a linear gradient from 30%
to 90% B for 5 min, and then an isocratic mixture for 15 min
before returning to the initial conditions (Wang et al., 2002).
The injection volume was 20 µL and flow rate was 0.6 mL
min-1.
Polyphenolic compounds were identified by an HPLC-
Finnigan MS detector and an LCQ Deca XP MAX (Thermo
Finigan, San Jose, CA) instrument with electrospray interface
(ESI) operating in negative ion mode. The analyses were car-
ried out using full scan data-dependent MSn scanning from
m/z 110 to 1500. Column and chromatographic conditions
were identical to those used for the HPLC-DAD analyses. The
injection volume was 10 µL and the flow rate 0.6 mL min-1.
The capillary temperature was 250 °C, the sheath gas was
60 units and auxiliary gas 15 units; the source voltage was
3 kV and normalized collision energy was between 20-35%.
Spectral data were elaborated using the Excalibur software
(Thermo Scientific).
The identification of compounds was confirmed by compar-
ing retention times and their spectra, as well as by adding the
standard solution to the sample and by fragmentation (Tables
2 and 3). Concentrations of phenolic compounds were calcu-
lated from peak areas of the sample and the corresponding
standards and expressed in mg 100 g-1 dry weight (DW). For
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compounds lacking standards, quantification was carried out
using compounds with structural similarities.
2.5. Total Phenolic Compounds (TPC) Assay
Quantification of TPC in rosemary extract (prepared using the
same way as the one for HPLC analysis, but without BHT) was
performed using spectrophotometer UV/Visible Evolution
220 (Thermo Scientific, San Jose, USA). TPC was determined
by Folin-Ciocalteu method (Mikulic-Petkovsek et al., 2013).
Tubes with 8.4 mL H2O, 0.5 mL 33% Folin-Ciocalteu phenol
reagent and 0.1 mL extract (except in blank) were vortexed and
after 3-6 min 1 mL of 20% Na2CO3 was added. Absorbance
was recorded at λ=765 nm after 1h of incubation at room
temperature. TPC was expressed as gallic acid equivalents
(GAE) in mg g-1 dry weight (DW).
2.6. Cytotoxic activity of rosemary extract, growth and cul-
ture of the cell lines
For the estimation of cell growth activity, one non-transformed
human cell line MRC-5 (fetal lung fibroblast, ECACC
84101801) and three human malignant transformed cell lines:
MCF-7 (breast adenocarcinoma ECACC No. 86012803), HeLa
(cervix epitheloidcarcinoma, ECACC No. 93021013) and HT-
29 (colon adenocarcinoma, ECACC No. 91072201) were used.
The cell lines were grown and maintained in Dulbecco’s Modi-
fied Eagle’s Medium - DMEM (Sigma-Aldrich, USA) medium
supplemented with Fetal Calf Serum - FCS (10%), penicillin
(100 Units mL-1) and streptomycin (100 µg mL-1), being re-
ferred to as complete medium. The cells were cultured in 25
cm2 flasks at 37 °C in the atmosphere of 5% CO2 and high
humidity, and sub-cultured twice a week. A single cell sus-
pension was obtained using 0.1% trypsin with 0.04% EDTA.
Cell growth was evaluated by the colorimetric sulforhodamine
B (SRB) assay (Rubinstein et al., 1990). Cell lines were plated
into 96-well microtiter plates (Sarstedt, Newton, USA) at dif-
ferent seeding density of 5×103 cells per well for MRC-5 and
MCF-7.4×103 cells for HeLa and 6×103 cells for HT-29 in a
volume of 180 µL, and pre-incubated in complete medium
supplemented with 5% FCS, at 37 °C for 24 h.
For the evaluation of the cell growth activity, dry extract of
Rosmarinus officinalis was diluted in mixture of DMSO and 0.9%
NaCl to obtain final concentrations in range of 500-1000 µg
mL-1 while in control cell group, mixture of DMSO and 0.9%
NaCl were added (DMSO concentration was under 0.2%).
For the co-treatment we have chosen antitumor drug BLM.
For investigations of co-effect of rosemary extract and BLM
on cell lines growth, the chosen final concentration of BLM
was 100 µg mL-1. This concentration of BLM was chosen
because higher concentrations of BLM can induce very high
frequency of micronuclei (MN), which was difficult to score
accurately. Serial dilutions of rosemary extract and BLM (20
µL well-1) were added to achieve required final concentrations.
Microplates were then incubated at 37 °C for an additional 48
h. Colour development was measured using Multiscan Ascent
(Labsystems; Helsinki, Finland) photometer at 540 nm against
620 nm as background. Results of cell growth activity were
expressed as mean ± SD of three independent experiments,
performed in quadruplicate.
The effect on cell growth was expressed as a percent of the
control and calculated as: (At/Ac)×100 (%), where At is the
absorbance of the test sample and Ac is the absorbance of the
control (Cˇetojevic´ Simin et al., 2015). Based on concentration-
cell growth curves, EC50 values (concentration that inhibit cell
growth by 50%) were determined using CalcuSyn Version 1.1
(Mike Hayball, Copyright Biosoft, 1996). Using EC50 values
obtained in a non-tumor cell line and in the respective tumor
cell line, non-tumor/tumor EC50 ratios (NT/T) were calcu-
lated for extract, combination of extract and drug. NT/T ratio
shows the efficiency of tested material effect on tumour cells
in comparison to healthy ones (Cˇetojevic´ Simin et al., 2015).
2.7. Statistical analysis
Values of biochemical parameters and the cell growth activity
were expressed as means ± standard error of determinations
made in triplicates and quadruplicate, respectively. Results
were tested by ANOVA followed by comparisons of means by
the Duncan’s test (P<0.05). Statistical analyses were performed
using STATISTICA for Windows version 13 (Dell Software)
and CalcuSyn Version 1.1 (Mike Hayball, Copyright Biosoft,
1996).
3. RESULTS
Plant material tested in this study belongs to Spanish type
of rosemary according to International Standard of rosemary
essential oil (ISO 1342, 2012). The yield of essential oil in the
above-ground parts of examined specimen (1.9% of rosemary
dry weight) permit the assignment of this species to oil-rich
representatives of the Lamiaceae family. Bearing in mind that
the yield of the hydrodistillation is much lower compared to
steam distillation, the yield of our sample was much higher
in comparison to the Algerian rosemary (0.4%), but lower in
comparison to the Iranian sample (2.6%) (Boutekedjiret et al.,
2003; Jamshidi et al., 2009).
Table 1. Essential oil composition of the rosemary
herba
Compound name RI %m/m
α-Thujene 932 0.31
α-Pinene 940 13.41
Camphene 955 4.36
β-Pinene 983 3.95
Myrcene 992 5.64
α-Phellandrene 1009 0.43
Carene 3-delta 1014 1.63
α-Terpinene 1020 0.46
p-Cymene 1028 0.70
1,8-Cineole 1035 32.99
γ-Terpinene 1064 0.79
Terpinolene 1090 1.02
Linalool 1100 1.43
Camphor 1144 15.55
Borneol 1167 3.17
Terpinen-4-ol 1179 0.97
α-Terpineol 1190 2.54
Verbenone 1206 1.88
Bornyl acetate 1287 2.60
Caryophyllene Z 1406 3.08
α-Humulene 1456 0.59
Caryophyllene oxide 1582 0.97
Total identified compounds / 98.47
The composition of the essential oil is summarized in Table
1. The percentage of identified components in the oil sample
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was 98.47%. Of the 22 components detected, all of them were
identified in the oil in amount higher than 0.1%. The sample
contained predominantly monoterpenes (93.8%), in which 1.8-
cineol (32.9%) and camphor (15.5%) were the dominant com-
pounds. A considerable amount of some other monoterpene
compounds was also identified: α-pinene (13.4%), myrcene
(5.6%), camphene (4.3%), β-pinene (3.9%), and borneol (3.2%).
Relative portion of sesquiterpenes was low (4.6%) with the
caryophyllene Z as the dominant component (3.1%).
The major polyphenolic constituents in investigated rosemary
herba were flavones, flavonols and phenolic acids. As it is
shown in Table 2, most of the phenolic acids were hydroxycin-
namic acids derivatives (caffeic and quinic acid derivatives).
Caffeic acid ester and rosmarinic acid derivatives were present
in the highest amount (69.2 mg 100 g-1).
A scale according to the content of flavones and
flavonols can be organised in the following order: lute-
olin>isorhamnetin>quercetin>kaempferol>apigenin (Table 3).
Beside these, low amounts of lignin medioresinol derivatives
(0.4 mg 100 g-1), as well as phenolic terpene epirosmanol (0.9
mg 100 g-1) isomers were also detected (Table 2). According
to our results TPC in investigated extract was 6.3 g GA 100
g-1, whereas the most abundant were luteolin-3-glucuronide
derivatives (Table 2).
The antitumor activity of rosemary extract without and with
BLM was evaluated in vitro by the colorimetric sulforho-
damine B (SRB) assay using human non-tumor MRC-5 and
three tumor cell lines MCF-7, HeLa and HT-29 (Figure 1).
Rosemary extract showed moderate activity regarding the cell
growth inhibition with EC50 values between 344.3 and 461.5
µg mL-1 (Table ??). There was no selective antiproliferative
activity of rosemary extract towards tumor cells in compar-
ison to non-tumor ones (NT/T ratio for all cancer cell line
was lower than 1). The most susceptible tumor cell line re-
garding R effect was HeLa (EC50 385.2 µg mL-1), then MCF-7,
while the lowest antitumor activity rosemary showed on HT-
29. Tested cell lines proved to have the same susceptibility.
Concentration-dependent effect was achieved experimentally,
by applying different concentrations of rosemary and BLM.
The antiproliferative activity at co-treatment was higher from
those with BLM only in MCF-7 cells (EC50, rosemary+BLM :
BLM = 58.9 : 119.8) (Table 4).
Antitumor activity of rosemary extract in combination with
BLM was higher in comparison to effect of extract solely on all
cell lines. Among tumour cells, most susceptible were MCF-
7 (7-fold more than for rosemary extract), then HeLa cells
(2.3-fold more than for rosemary extract), while HT-29 cells
were the least susceptible (1.58-fold more than for rosemary
extract). NT/T ratio was 1.0 for HeLa and 2.9 for MCF-7 cells,
pointing to moderate selective response of rosemary extract in
combination with BLM regarding the breast adenocarcinoma
tumour type.
4. DISCUSSION
Regarding the investigations about combined administration
of natural compounds and antineoplastic drugs, there are
comprehensive possible benefits of such therapy. They might
be reflected through lowering the dosage of conventional
medicines and consequently decreasing the toxicity of anti-
neoplastic drugs on healthy cells followed by higher cytotoxic
effects toward cancer cells. Authentic samples of essential
oil of rosemary harvested in coastal areas of California, Cor-
sica, Croatia or Haute Provence differ significantly in their
respective content of cineole, camphor, bornyl acetate and
verbenone. Samples with low camphor and high verbenone
contents are referred to as “rosemary verbenone” (California,
Corsica) (Schnaubelt, 2011). This oil has been recognized for
its specific mucolytic properties and its usefulness for skin
care formulas. The Haute Provence variety with high cineole
and high camphor content is used in aromatherapy as well
as for its expectorant and anti-infectious effects. Rosemary
essential oil from the islands of the Adriatic coast of Croatia
has a composition squarely in the middle, with a camphor
content of approximately 10%. Our result for camphor content
(15.5%) is somewhat above this, presumably because the Krk
Island is located in the North of the Adriatic Sea and very
close to mountainous mainland, with strong cold winds dur-
ing winter and spring. It is known that camphor and α-pinene
have been related to antioxidant activities (Sedighi et al., 2015),
whereas antiproliferative activity has been ascribed to 1,8-
cineol even for antiproliferative effect, leading to apoptosis in
the leukemia cell (Kladniew et al., 2014).
The content and composition of phenolic compounds is very
important due to their antitumor activity. For example,
flavones act against cancer through antioxidant reactions in
cells (Ren et al., 2003). Furthermore, their role in inhibition
of angiogenesis, promotion and differentiation, as well as
in apoptosis is well defined (Ren et al., 2003; Ivanova et al.,
2014b). Also, flavonoids can play sensitizing role in malig-
nant cells exposed to conventional chemotherapeutics through
modifying the molecular events that control the cell growth,
differentiation and programmed cell death (Ivanova et al.,
2014b). Among the flavons and flavonols in the examined ex-
tract, the most common are luteolin-3-glucuronide derivatives.
More recent studies highlight luteolin as a compound with
strong selective anticancer activity that potentiates with dose
increase (Goodarzi et al., 2018; Seydi et al., 2018).
Some authors (Munné-Bosch et al., 2000) reported that isoros-
manol, rosmanol, carnosol, 11,12-di-O-methylisorosmanol,
carnosic acid and 12-O-methylcarnosic acid are main phenolic
diterpens found in leaves of rosemary grown in the Mediter-
ranean region. However, their investigations concluded that
content of phenolic diterpens varies during the vegetation
season, as well as due to some abiotic factors, such as: relative
water content of the leaf, high solar radiation and temperature.
Rosemary plants subjected to enhanced water deficit, salin-
ity, intense light, and heat stress seem to have lower carnosic
acid concentrations (Tounekti and Munné-Bosch, 2012), which
could explain the deficit of these compounds in our samples.
Extract used in this study, as opposed to the low concentra-
tion of carnosic acid, is characterized with presence of other
biologically active components, among which mostly flavons,
as well as caffeic and rosmarinic acid derivatives.
Previous study showed that rosmarinic acid has low cytotoxic
effect on cell lines and low effect on the cell viability (Yesil-
Celiktas et al., 2010). Caffeic acid initiates the fibrosarcoma
cancer cell death by decreasing cell proliferation, increasing
intracellular reactive oxygen species (ROS), alteration in mi-
tochondrial membrane potential, lipid peroxidation, DNA
damage and apoptosis (Prasad et al., 2011). Also, caffeic acid
phenethyl ester has a possibility to induce apoptosis via Fas
signal activation in human breast cancer MCF-7 cells (Watabe
et al., 2004). It is known that rosmarinic acid blocks the pro-
liferation induced by tumor necrosis factor-alpha or platelet-
derived growth factor (PDGF). These effects occur at both the
G0–G1 and G1–S phases of cell division (Makino et al., 2000).
Present investigation confirmed that methanol extract of rose-
mary, with proven predominant flavons and derivatives of
caffeic and rosmarinic acid, led to a moderate inhibition of cell
growth for all investigated cell lines, with cervix carcinoma
cell line as the most susceptible to the activity of the extract,
and colon carcinoma cell line as the least susceptible.
The study of Borrás-Linares et al. (2015) on colon adenocar-
cinoma HT-29 and SW480 cells investigated the compara-
tive antiproliferative and cytotoxic feature of rosemary and
its fractions with review on their potential synergistic ef-
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Table 2. Characterisation and content of phenolic acids and other polyphenols in rosemary herba (results are presented as
mean ± standard deviation)
Rt (min) [M-H]- (m/z) MS2 [M-H]- (m/z) Tentative identification mg per 100 g-1 DW
12.2 341 179, 281, 251 caffeoyl-hexoside derivative 1 2.24±0.09
13.2 341 281, 251, 179 caffeoyl-hexoside derivative 2 7.97±1.10
15.0 353 179, 173, 191, 136 4-O-caffeoylquinic acid derivative 1 0.15±0.00
16.4 353 179, 173, 191, 136 4-O-caffeoylquinic acid derivative 2 0.29±0.00
19.4 371 353 caffeic acid derivative 0.91±0.00
26.4 677 515, 353, 329,509, 191 1,3,5-tri-O-caffeoylquinic acid 0.94±0.00
15.0 387 207 medioresinol derivative 1 0.12±0.00
15.1 387 207 medioresinol derivative 2 0.24±0.00
36.1 359 161, 197, 225 rosmarinic acid derivative 1 59.85±2.31
34.5 359 161, 197, 314 rosmarinic acid derivative 2 0.85±0.01
35.4 359 161, 197, 314 rosmarinic acid derivative 3 0.50±0.00
35.5 359 161, 197, 314 rosmarinic acid derivative 4 2.98±0.51
25.4 549 387, 489 rosmarinic acid derivative 5 3.94±1.13
21.6 521 359, 161, 197 rosmarinic acid hexoside 1.05±0.07
32.7 299 137 hydrobenzoic acid hexoside 4.62±0.07
33.8 345 301, 283 epirosmanol derivative 1 3.54±0.06
33.9 345 301, 283 epirosmanol derivative 2 1.86±0.03
Table 3. Characterisation and content of flavones and flavonols in rosemary herba (results are presented as mean ± standard deviation)
Rt (min) [M-H]- (m/z) MS2 [M-H]- (m/z) Tentative identification mg per 100 g-1 DW
16.9 593 503, 491 apigenin-6,8-C-diglucoside (vicenin II) 1.63±0.02
23.0 597 447, 285 luteolin-rhamnoglucoside (luteolin-7-rutinoside) 16.17±0.12
24.2 461 285 luteolin-3-glucuronide 1 16.47±0.14
25.3 461 285 luteolin-3-glucuronide 2 13.55±0.09
27.6 461 285 luteolin-3-glucuronide 3 85.28±0.19
17.2 503 285, 399 luteolin-3-O-(O-acetyl)-β-D-glucuronide derivative 1 12.02±0.07
30.8 503 285, 399 luteolin-3-O-(O-acetyl)-β-D-glucuronide derivative 2 44.73±0.21
31.8 503 285, 399 luteolin-3-O-(O-acetyl)-β-D-glucuronide derivative 3 62.81±1.30
32.1 503 285, 443 luteolin-3-O-(O-acetyl)-β-D-glucuronide derivative 4 49.84±1.24
31.5 607 299 diosmetin-8-C-rhamnosyl-7-O-glucoside (diosmin) 20.02±0.14
25.6 609 447, 285 kaempferol-3,7-di-O-glucoside 8.27±0.02
22.0 593 285 kaempferol-3-O-rutinoside 5.14±0.01
12.8 477 315 isorhamnetin hexoside 5.95±0.05
23.5 477 315, 301 isorhamnetin-3-O-hexoside derivative 1 31.37±1.10
25.7 477 315, 301 isorhamnetin-3-O-hexoside derivative 2 2.32±0.04
24.8 491 315, 300 isorhamnetin-3-O-glucuronide 2.72±0.09
25.9 639 477, 315, 300 isorhamnetin-3,7-diglucoside 10.81±1.12
22.7 623 315, 299, 477 isorhamnetin-3-O-rhamnosyl hexoside derivative 1 3.94±0.07
27.1 623 315, 300 isorhamnetin-3-O-rhamnosyl hexoside derivative 2 3.50±0.06
27.8 623 315, 300 isorhamnetin-3-O-rhamnosyl hexoside derivative 3 6.09±0.07
19.9 609 301 quercetin-3-rhamnosyl hexoside derivative 1 4.99±0.03
24.5 609 301 quercetin-3- rhamnosyl hexoside derivative 2 16.47±0.09
20.5 463 301 quercetin-3-O-glucoside 8.72±0.13
23.9 625 301, 463 quercetin-dihexoside 16.47±0.17
27.8 653 315, 300 quercetin-diglucuronide 8.78±0.07
fects. The phenomenon of synergism was also investigated
by Lewandowska et al. (2014), who presented a review of
studies which confirms that rosemary constituents potentiate
the effectiveness of conventional chemotherapeutics, as well
as other compounds of plant origin, on MCF7 and HT29 cell
lines. Previous data indicate that low-toxic conventional syn-
thetic antioxidants, as well as antioxidant constituents from
rosemary and other plants may have important role in process
of sensitization of irradiated and chemotherapeutic-treated tu-
mor cells (Plouzek et al., 1999; Berdowska et al., 2013; Ivanova
et al., 2014b). Berdowska et al. (2013) confirmed the antipro-
liferative activity of polyphenol plant extract components on
adriamycin resistant MCF-7 cells through MTT test. It is in-
teresting that tested polyphenolics exhibited more beneficial
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Fig. 1. Effect of rosemary with and without bleomycin (100 µg mL-1) on growth of cell lines at 48h treatment. Results are shown as mean ±
standard deviation of three independent experiments, performed in quadruplicate.
Fig. 2. Appearance of cells treated by rosemary with and without bleomycin (100 µg mL-1) during 48h treatment, (magnification 400x). R-
rosemary extract, BLM-bleomycin
properties when they were applied in the form of extracts
comprising their mixtures than individually (Berdowska et al.,
2013).
CONCLUSION
Results of this study showed that the major polypheno-
lic constituents in investigated rosemary extract were phe-
nolic acids (rosmarinic acid and its derivatives), as well
as flavones and flavonols in the following order: lute-
olin>isorhamnetin>quercetin>kaempferol>apigenin. Regard-
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Table 4. EC50 values (µg ml-1) and non-tumor/tumor EC50 ratios
(NT/T) in human cell lines.
Cell line Ra R + BLM BLM
MRC-5 344.32 170.81 80.3
MCF-7 407.91 58.6 119.81
HeLa 385.15 162.85 77.2
HT-29 461.54 291.27 165.31
MCF-7 (NT/T) 0.84 2.91 0.67
HeLa (NT/T) 0.89 1.05 1.04
HT-29 (NT/T) 0.75 0.59 0.49
a EC50 values for effect of rosemary extract (R) and bleomycin were established
for bleomycin (BML) concentration of 100 µg ml-1
ing the antiproliferative activity, we confirmed that treatment
with rosemary extract led to moderate inhibition of cell growth
for all investigated cell lines, where the most susceptible to
rosemary effect was cervix carcinoma cell line, and the least
susceptible was colon carcinoma cell line. The antiprolifera-
tive activity at co-treatment was higher from those with BLM
in breast cancer cells alone. This combination also potentiates
the antiproliferative effect of rosemary extract in all investi-
gated cancer cell lines, with 7 times increased effect on breast
cancer cells compared to the effect of rosemary extract alone.
Co-treatment with BLM causes moderate selectivity to breast
and cervical cancer cells compared to healthy cells.
To the best of our knowledge, this study represents the first re-
port on the antiproliferative effects of combination of rosemary
extract and antineoplastic drug bleomycin, in spite of their
wide single use and numerous studies on the subject. Consid-
ering these conclusions and our present results, we suggest
the usage of rosemary extract in combination with the stan-
dard chemotherapeutics, for further studious investigations
on a variety of human cancer cell lines.
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